Prne
July 6th, 2009
AARHUS, Denmark - Unisense FertiliTech A/S ( www.fertilitech.com) announces that the EmbryoScope(TM) Embryo Monitoring System and EmbryoSlide(TM) tray have received CE approval as class IIa medical devices for use in IVF. Unisense Fertilitech A/S also received the DS/EN ISO13485:2003 and AC:2007 quality system certificate for production, installation and servicing of IVF incubators and related accessories
(Photo: www.newscom.com/cgi-bin/prnh/20090706/353010 )
Francesca Bahr, sales manager at Unisense FertiliTech A/S says “the CE mark will allow us to market the instrument to Assisted Reproduction clinics across Europe, with the goal of improving embryo assessment and to facilitate the goal of elective single embryo transfer”.
During IVF treatment, multiple oocytes are removed from the patient and fertilized in-vitro. The resulting fertilized eggs are cultured for a period of 2 to 5 days, before the embryologist must select the best potential embryo or embryos to transfer to the patient. Ideally, a single embryo resulting in a single pregnancy is optimal as multiple pregnancies present risks to maternal and fetal health.
A major challenge for the embryologist is determining which embryos have the best potential to create a single healthy baby.
The EmbryoScope(TM) Monitoring System allows uninterrupted observation of embryo development in a stable environment. Embryo quality parameters can be assessed and reviewed without the potentially damaging effects of removing the embryo from a controlled incubation environment. Retrospective analysis of development will allow embryologists to identify potentially new parameters for embryo analysis.
Mette Munch, Director of regulatory affairs at Unisense FertiliTech A/S says she will now set her goal on FDA 510K clearance in order to facilitate marketing to clinics in the United States.
The Announcement of the CE mark coincided with the successful sales launch of the EmbryoScope(TM) Embryo Monitoring System at the European society of Human reproduction and Embryology in Amsterdam, June 29.July 1 2009
Unisense Fertilitech A/S is a Danish company which was founded in 2003, as a daughter company of Unisense A/S. The company develops and manufactures instruments and analysis solutions to facilitate in-vitro Fertilization. The company is currently involved in various international research projects involving embryo selection and analysis, embryo respiration and stem cell research.
Website URL www.fertilitech.com
Source: Unisense Fertilitech A/S
Contact Person: Francesca Bahr, Sales and Marketing Manager, Unisense FertiliTech A/S, Mobile Phone: +45-40255538, Email Address fab at fertilitech.com
Filed under Biotechnology, Clinical Trials / Medical Discoveries, FDA Approval, Government and Policy, Health, Health Care / Hospitals, Pharmaceuticals | Tags: Aarhus, Analysis, denmark, Unisense Fertilitech A/S | Comment Below
Related Press Releases EquiLend Obtains Regulatory Approval as an Automated Trading System in OntarioSeptember 27th, 2009 NEW YORK -
EquiLend is pleased to announce that they have obtained regulatory approval as an automated trading system (ATS) in Ontario, Canada. The approval by the Ontario Securities Commission and the Investment Industry Regulatory Organization of Canada allows EquiLend to offer trading services to clients in the province. Neopharma Receives Approval From UAE Ministry of Health to Manufacture H1N1 MedicineSeptember 27th, 2009 DUBAI, UAE - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, today announced it has received clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu. The approval comes at a time when the entire region is stepping up efforts to tackle the H1N1 pandemic. vProtect Luminal Shield (TM) from Prescient Medical Receives CE MarkAugust 23rd, 2009 DOYLESTOWN, Pennsylvania -
- Novel Self-Expanding Platform for Treatment of Coronary Artery Disease Receives European Regulatory Clearance
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease. CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic TechnologyAugust 3rd, 2009 ATLANTA -
CryoLife, Inc., (NYSE: CRY) an implantable biological medical device and cardiovascular tissue processing company, today announced it has received CE mark approval for its BioFoam(R) Surgical Matrix (BioFoam). The CE mark allows immediate, unrestricted commercial distribution of BioFoam in the European Community for use as an adjunct in the sealing of abdominal parenchymal tissues (liver and spleen) when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. Long-term Investment Secured - Swiss Foundation Supports Innovative Concept for Patients With DiabetesJuly 2nd, 2009 ZÜRICH - Solianis recently signed an investment agreement with a Swiss foundation which invests its assets in Swiss companies. According to the agreement, this foundation will put CHF 5 million, while the previous investors in Solianis are investing another CHF 3 million. CSafe Announces Its AcuTemp Air Cargo Container Receives EASA ApprovalMay 17th, 2009 DAYTON, Ohio - The only active RKN to obtain approvals from both US and European aviation agencies
CSafe, LLC, provider of technology solutions for the temperature sensitive airfreight market, today announced its AcuTemp(R) RKN (www.csafellc.com) received approval from the European Aviation Safety Agency (EASA), making it the first and only active RKN of its kind to obtain approvals from both EASA and the US Federal Aviation Administration (FAA). (Logo: www.newscom.com/cgi-bin/prnh/20090518/LA18165LOGO)
"Obtaining this EASA approval permits the use of the AcuTemp RKN by more customers throughout the world," said Brian Kohr, general manager of CSafe, LLC. Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) InhibitorMay 12th, 2009 NERVIANO, Italy - The FDA has approved an Investigational New Drug (IND) application by Nerviano Medical Sciences to begin a phase I clinical study with its selective PLK-1 small molecule inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for the proliferation of cancer cells. Occlutech Obtains CE Mark for the new Generation PFO & ASD OccludersMay 11th, 2009 JENA, Germany - Occlutech, the leading European developer of septum occluders, today announced that it has obtained CE mark approval for its new generation ASD and PFO occluders, the Figulla Flex. The Figulla Flex ASD and PFO occluders encompass a new innovative delivery system, making the use of a threaded hub unnecessary. Mask for Swine Flu & the Masking of Your Immune SystemApril 30th, 2009 LONDON and BRIGHTON - With experts warning that four in ten people could catch the killer swine flu within months, the government have ordered 32 million protective face masks to help combat the disease. However, face masks could prove useless as your breath makes them damp and the virus can seep in!
Even anti-viral drugs don't kill the virus, they only stall their development. Orcrist Bio Inc. Receives Approval From European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750April 5th, 2009 CALGARY, Canada - Orcrist Bio Inc. (ORC) a biotechnology company developing stem cell-mobilizing pharmaceuticals, announced today the approval of its Phase I, open-label, single-ascending-dose, safety study of HYC750 in healthy male volunteers, by the European Competent Authority in Seville, Spain.
Related News Ohio woman implanted with wrong embryo gives birth to 'healthy baby boy'September 25th, 2009 Ohio woman implanted with wrong embryo deliversTOLEDO, Ohio — An Ohio woman who had the wrong embryo implanted by a fertility clinic has given birth to a boy. Sean and Carolyn Savage said in a statement that the 'healthy baby boy" was delivered Thursday at St. Ohio woman with wrong embryo gives birth; biological parents call surrogate 'guardian angel'September 26th, 2009 Ohio woman with wrong embryo gives birthTOLEDO, Ohio — The biological parents of a baby boy born to a woman who had the wrong embryo implanted by a fertility clinic say they will be "eternally grateful" to her. Paul and Shannon Morell of suburban Detroit said in a statement Saturday said the baby was born Thursday at five pounds, three ounces and 18 inches long. Novel method of assessing women's eggs may boost IVF successMarch 24th, 2009 WASHINGTON - In a major advance towards successful in-vitro fertilization (IVF), scientists have developed a new method to assess the quality of women's eggs and determine which are more likely to result in pregnancies. Barry Behr, PhD, HCLD, associate professor of obstetrics and gynecology at the Stanford University School of Medicine and director of Stanford's IVF laboratory, described a way to "profile" the eggs to know their chances of success. Ohio woman says she never considered seeking custody of baby she's mistakenly carryingSeptember 23rd, 2009 Ohioan maintains resolve while carrying wrong babyTOLEDO, Ohio — An Ohio woman is carrying another couple's child after she says a fertility clinic implanted her with the wrong embryo. Similar cases have degenerated into custody battles and ugly lawsuits. Mystery behind how plants make eggs solvedJune 5th, 2009 WASHINGTON - In a landmark discovery, scientists at the University of California, Davis, have found that a hormone called auxin is responsible for egg production in plants. It is the first definitive study of a plant hormone acting as a morphogen-a substance that directs the pattern of development of cells based on its concentration. Parents of baby born to Ohio mother implanted with wrong embryo call her 'guardian angel'September 26th, 2009 Biological parents call surrogate 'guardian angel'TOLEDO, Ohio — The biological parents of a baby boy born to an Ohio woman who had the wrong embyro implanted by a fertility clinic say they will be "eternally grateful" to her. Paul and Shannon Morell of suburban Detroit said in a statement Saturday said the baby was born Friday at five pounds, three ounces and 18 inches long. Now, a non-invasive system to monitor foetal heartbeat earlierJune 2nd, 2009 WASHINGTON - Scientists have developed a new non-invasive system to allow much earlier monitoring of the foetal heartbeat. While tiny fluctuations in a foetus' heartbeat can indicate distress, currently there is no way to detect such subtle variations except during labour, when it could be too late to prevent serious or even fatal complications. Ohio woman implanted with Mich. woman's embryo gives birth to healthy boy, will give him upSeptember 25th, 2009 Ohio woman implanted with wrong embryo gives birthTOLEDO, Ohio — A woman who had the wrong embryo implanted by a fertility clinic has given birth to a boy, her family said Friday. Sean and Carolyn Savage released a statement Friday night saying a "healthy baby boy," whom they plan to give up to his biological parents, was delivered Thursday at St. China to set up 'pre-emptive' food safety network: officialDecember 30th, 2008 BEIJING - The Chinese government is preparing a 'pre-emptive' monitoring system to ensure food safety to prevent recurrence of the countrywide tained baby food scandal that killed six infants and sickened nearly 30,000. 'It means we will try to rid food problems by early detection, early warning and early intervention,' Su Zhi, deputy general director of health inspection and supervision bureau in the health ministry, said Wednesday. Parents of baby born to Ohio woman implanted with wrong embryo call her 'guardian angel'September 26th, 2009 Wrong-embryo baby's parents laud 'guardian angel'TOLEDO, Ohio — An Ohio woman who gave birth to a baby boy after a fertility clinic implanted her with the wrong embryo is a "guardian angel," the boy's biological parents said Saturday. Paul and Shannon Morell of suburban Detroit said in a statement that they would be "eternally grateful" to Carolyn Savage, of Sylvania, for her decision to give birth to their child despite the clinic's mistake.
|
|
